Monoclonal Antibody Therapeutics Market Size, Share and Forecast 2026
April 2019, CASI Pharmaceuticals signed an exclusive worldwide rights license agreement for the investigational anti-CD38 monoclonal antibody TSK011010 program from Black Belt Therapeutics Limited.
(EMAILWIRE.COM, September 09, 2019 ) Market Overview:
The Monoclonal Antibody Therapeutics market is expected to grow at a CAGR of XX% to reach a market value of USD XX billion by 2026.
Monoclonal Antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to bind monospecifically to certain cells or proteins.
Market Dynamics:
The market for the Monoclonal Antibody Therapeutics Market is primarily driven by the rising incidence of cancer and other chronic diseases coupled with the rise in R&D activities in genomics.However, higher costs and strict regulatory measures resulting in lengthy approval procedures may restrict the market growth.
Market Segmentation:
Based on Product Type, the market for Monoclonal Antibody Therapeutics is segmented into:
• Naked
• Fusion Protein
• Antibody fragment
• Conjugate
• Multi-specific
Humanized Monoclonal Antibody accounts for the largest revenue share owing to its widespread adoption for numerous diseases including cancer, autoimmune diseases, and inflammatory diseases.
By Application, the global market for Monoclonal Antibody Therapeutics is segmented into:
• Cancer
• Autoimmune Diseases
• Infectious Diseases
• Haematological Diseases
• Others
By End-User, the global market for Monoclonal Antibody Therapeutics is segmented into:
• Hospitals
• Private Clinics
• Research Institutes
By Source, the global market for Monoclonal Antibody Therapeutics is segmented into:
• Human
• Humanized
• Chimeric
• Others
Geographical Analysis:
By geography the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players are:
• ImmunoGen, Inc.
• Bayer AG
• Biogen
• Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Amgen, Inc.
View full report: https://www.datamintelligence.com/research-report/monoclonal-antibody-therapeutics-market
Download free sample: https://www.datamintelligence.com/download-sample/monoclonal-antibody-therapeutics-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
The Monoclonal Antibody Therapeutics market is expected to grow at a CAGR of XX% to reach a market value of USD XX billion by 2026.
Monoclonal Antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to bind monospecifically to certain cells or proteins.
Market Dynamics:
The market for the Monoclonal Antibody Therapeutics Market is primarily driven by the rising incidence of cancer and other chronic diseases coupled with the rise in R&D activities in genomics.However, higher costs and strict regulatory measures resulting in lengthy approval procedures may restrict the market growth.
Market Segmentation:
Based on Product Type, the market for Monoclonal Antibody Therapeutics is segmented into:
• Naked
• Fusion Protein
• Antibody fragment
• Conjugate
• Multi-specific
Humanized Monoclonal Antibody accounts for the largest revenue share owing to its widespread adoption for numerous diseases including cancer, autoimmune diseases, and inflammatory diseases.
By Application, the global market for Monoclonal Antibody Therapeutics is segmented into:
• Cancer
• Autoimmune Diseases
• Infectious Diseases
• Haematological Diseases
• Others
By End-User, the global market for Monoclonal Antibody Therapeutics is segmented into:
• Hospitals
• Private Clinics
• Research Institutes
By Source, the global market for Monoclonal Antibody Therapeutics is segmented into:
• Human
• Humanized
• Chimeric
• Others
Geographical Analysis:
By geography the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players are:
• ImmunoGen, Inc.
• Bayer AG
• Biogen
• Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Amgen, Inc.
View full report: https://www.datamintelligence.com/research-report/monoclonal-antibody-therapeutics-market
Download free sample: https://www.datamintelligence.com/download-sample/monoclonal-antibody-therapeutics-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results